Bristol-Myers Squibb Co

BMY:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:52 PM EST
66.50quote price arrow up+0.25 (+0.38%)
Volume
235,128
Close
66.25quote price arrow down-0.49 (-0.73%)
Volume
9,349,448
52 week range
45.76 - 68.34

...

Loading . . .

KEY STATS

  • Open66.57
  • Day High66.82
  • Day Low66.00
  • Prev Close66.74
  • 52 Week High68.34
  • 52 Week High Date01/22/20
  • 52 Week Low45.76
  • 52 Week Low Date03/23/20
  • Market Cap149,708.44M
  • Shares Out2,259.75M
  • 10 Day Average Volume12.39M
  • Dividend1.96
  • Dividend Yield2.96%
  • Beta0.62
  • 1 Year % Change-0.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.11
  • P/E (TTM)-599.01
  • Fwd P/E (NTM)9.69
  • EBITDA (MRQ)14,973.00M
  • ROE (MRQ)-0.13%
  • Revenue (MRQ)39,395.00M
  • Gross Margin (MRQ)71.52%
  • Net Margin (MRQ)-0.07%
  • Debt To Equity (MRQ)89.61%

EVENTS

  • Earnings Date02/04/2021
  • Ex Div Date12/31/2020
  • Div Amount0.49
  • Split Date-
  • Split Factor-

Latest Bristol-Myers Squibb Co News

Latest BMY News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its...
Giovanni Caforio M.D.
Chairman
David Elkins
Chief Financial Officer
Kathryn Metcalfe
Executive Vice President
Elizabeth Mily
Executive Vice President
John Elicker
Executive Vice President
Address
430 E 29th St Fl 14
New York, NY
10016-8367
United States